Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic
- 13 December 2000
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 16 (4) , 527-530
- https://doi.org/10.1016/s0924-8579(00)00290-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year AnalysisClinical Infectious Diseases, 1999
- Successful Treatment of Persistent Vancomycin‐Resistant Enterococcus faecium Bacteremia with Linezolid and GentamicinClinical Infectious Diseases, 1999
- National Nosocomial Infections Surveillance (NNIS) Report, data summary from October 1986–April 1996, issued May 1996American Journal of Infection Control, 1996
- The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory CommitteeJAMA, 1995
- Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?Diagnostic Microbiology and Infectious Disease, 1994
- Methicillin-ResistantStaphylococcus aureus in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- Emergence of Multiply Resistant PneumococciNew England Journal of Medicine, 1978
- A RESISTANT PNEUMOCOCCUSThe Lancet, 1967
- "Celbenin" - resistant StaphylococciBMJ, 1961